Terns Pharmaceuticals, Inc. (TERN) Social Stream
Terns Pharmaceuticals Inc (TERN) Price Targets From Analysts
Use the tables below to see what analysts covering Terns Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
TERN's average price target has moved down $23 over the prior 35 weeks.
Over the past 50 weeks, TERN's average upside potential has been 138.6%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
TERN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Terns Pharmaceuticals Inc's variance in analysts' estimates is lower than nearly 100% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, Terns Pharmaceuticals Inc's number of analysts covering the stock is greater than 9.38% of them.
- Terns Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 237.55% of stocks in the small market cap category.
- In the context of Healthcare stocks, Terns Pharmaceuticals Inc's average analyst price target is greater than 70.07% of them.
In the Pharmaceutical Products industry, TCDA, SYRS, and SYBX are the three stocks most similar to Terns Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Is TERN a Buy, Hold or Sell? See the POWR Ratings now!